Search for data related to genes or regions
+
279 Study Datasets reported containing markers in gene or region chr12:13234..4534534 (no 5′ and no 3′ flanks) with -log p ≥ 0
Pages: 1 2 3 4 5 6
No data sets (in No Phenotypes) added to Browser
Phenotype tested in Study Phenotype ontology annotation Total p-values in Study StudyAdd data sets to Browser Related Study data
Strict autism (HGVPM3674)
  • Autistic Disorder
13,304 GWAS of Autism spectrum disorder (HGVST1842)
Stroke (HGVPM546)
  • Stroke
1 GWAS of stroke (HGVST302)
Sum eosinophil basophil counts (HGVPM3860)
  • Leukocyte Count
198 GWAS of Hematological traits (HGVST1903)
Survival in pancreatic cancer (HGVPM5249)
  • Pancreatic Neoplasms
61 GWAS of Survival in pancreatic cancer (HGVST2675)
Systolic blood pressure (HGVPM6264)
  • Blood Pressure
70 GWAS of Blood pressure (HGVST3204)
Systolic blood presure (HGVPM563)
  • Blood Pressure
959,443 GWAS of systolic blood pressure in a British population (HGVST307)
Tardive dyskinesia (HGVPM1699)
  • Movement Disorders
479,554 GWAS of movement-related adverse antipsychotic effects (HGVST461)
Temporomandibular joint disorders (HGVPM3130)
  • Temporomandibular Joint Disorders
1 GWAS of Temporomandibular joint disorders (HGVST1649)
TMAO / Betaine (HGVPM3628)
  • Methylamines
  • Betaine
2,538 GWAS of Metabolite quantitative traits (HGVST1827)
Total body bone mineral density (HGVPM6432)
  • Bone Density
181 GWAS of Bone mineral density (HGVST3297)
Total cholesterol (HGVPM3730)
  • Cholesterol
5,863 GWAS of Serum lipid levels (HGVST1854)
Triglyceride (HGVPM3731)
  • Triglycerides
5,871 GWAS of Serum lipid levels (HGVST1854)
Two-hour glucose challenge (HGVPM769)
  • Blood Glucose
5 GWAS of glucose levels 2 hours after an oral glucose challenge (HGVST433)
Type 2 diabetes (HGVPM4780)
  • Diabetes Mellitus, Type 2
41 GWAS of Type 2 diabetes (HGVST2443)
Type 2 diabetes (HGVPM5032)
  • Diabetes Mellitus, Type 2
64 GWAS of Type 2 diabetes (HGVST2558)
Type 2 diabetes (HGVPM5545)
  • Diabetes Mellitus, Type 2
90 GWAS of Type 2 diabetes (HGVST2815)
Type I diabetes (HGVPM149)
  • Diabetes Mellitus, Type 1
629 GWAS and meta-analysis of type I diabetes mellitus (HGVST103)
Type II diabetes (HGVPM4)
  • Diabetes Mellitus, Type 2
612,486 GWAS of type II diabetes mellitus (HGVST5)
Type II diabetes (HGVPM5)
  • Diabetes Mellitus, Type 2
772,550 GWAS of type II diabetes mellitus (HGVST3)
Tyrosine (HGVPM3641)
  • Tyrosine
2,446 GWAS of Metabolite quantitative traits (HGVST1827)
Ulcerative colitis (HGVPM1256)
  • Colitis, Ulcerative
103 GWAS of ulcerative colitis (HGVST730)
Upper lip thickness (HGVPM3670)
  • Lip
11,167 GWAS of Facial features (HGVST1841)
Urate levels in lean individuals (HGVPM6115)
  • Uric Acid
30 GWAS of Urate levels (HGVST3111)
Valine (HGVPM3606)
  • Valine
2,696 GWAS of Metabolite quantitative traits (HGVST1827)
variant (vCJD) (HGVPM3052)
  • Creutzfeldt-Jakob Syndrome
0 GWAS of prion diseases (HGVST1013)
Visual contrast sensitivity (HGVPM3055)
  • Contrast Sensitivity
642,752 Variants in the 1q21 risk region are associated with a visual endophenotype of autism and schizophrenia (HGVST1611)
Waist-hip ratio (HGVPM1114)
  • Waist-Hip Ratio
8 Meta-analysis of 32 genome-wide association studies for waist hip ratio adjusted for body mass index (HGVST641)
Weight (HGVPM246)
  • Body Weight
9 GWAS of obesity-related traits (HGVST194)
White blood cell count (HGVPM3889)
  • Leukocyte Count
174 GWAS of Hematological traits (HGVST1903)